
	Three months ended June 30,						Six months ended June 30,
	2022			2023			2022			2023
	Shares	Fair Value		Shares	Fair Value		Shares	Fair Value		Shares	Fair Value
Granted(1)	—	$	—	—	$	—	—	$	—	142,020	$	4,634
Returned for payroll taxes	(49)	$	(2)	39	$	1	4,136	$	205	1,473	$	50
Cancelled	450	$	16	776	$	27	1,450	$	47	1,826	$	61

(1)

Restricted stock granted during the six months ended June 30 2023 vests over a three-year period, if the employee has remained continuously employed by us during the vesting period, at a weighted average stock price of $32.63.

We recorded stock-based compensation expense, which is included in General, administrative and other expenses, for restricted stock awards of $40,000 and $394,000, for the three months ended June 30, 2022 and 2023, respectively and $97,000 and $572,000 for the six months ended June 30, 2022 and 2023, respectively.


	Three months ended June 30,						Six months ended June 30,
	2022			2023			2022			2023
	Shares	Fair Value		Shares	Fair Value		Shares	Fair Value		Shares	Fair Value
Granted(1)	—	$	—	—	$	—	58,500	$	959	214,191	$	2,506
Granted(2)	—	$	—	—	$	—	310,000	$	5,388	—	$	—
Cancelled	18,138	$	214	13,810	$	152	25,138	$	285	101,850	$	1,334



(1)			Stock options granted during the six months ended June 30, 2022 and 2023 had a weighted average price of $49.48 and $32.69, respectively. The fair value of these options was calculated using the Black-Scholes option pricing model. The options granted in 2022 vest over a five-year period and have a ten-year term. The options granted in 2023 vest over a three-year period and have a ten-year term. These options will vest if the employee has remained continuously employed by us through the vesting period.
(2)			Stock options granted during the six months ended June 30, 2022 had a weighted average price of $49.48. The fair value of these options was calculated using the Black-Scholes option pricing model and vest over a seven-year period and have a ten-year term. These options will vest if the employee has remained continuously employed by us through the vesting period.


Grant Date												February 22, 2023
Expected holding period (years)												4.00
Awards granted												214,191
Dividend yield												1.38%
Expected volatility												43.68%
Risk-free interest rate												4.27%
Black-Scholes value												$11.70


	Three months ended June 30,						Six months ended June 30,
	2022			2023			2022			2023
	Shares	Cash		Shares	Cash		Shares	Cash		Shares	Cash
Exercised(1)	—	N/A		17,300	N/A		18,736	N/A		29,300	N/A
Returned for option price(2)	—	$	—	12,652	$	—	8,125	$	60	22,797	$	—
Returned for payroll taxes(3)	—	$	—	736	$	20	1,601	$	82	1,465	$	41



(1)			Stock options exercised during the three months ended June 30, 2023 had a weighted average exercise price of $20.06 with an aggregate intrinsic value of $0.2 million. Stock options exercised during the six months ended June 30, 2022 and 2023 had a weighted average exercise price of $25.88 and $22.26, respectively, with an aggregate intrinsic value of $0.5 million and $0.3 million, respectively.
(2)			Represents shares withheld/cash received for the payment of the option price.
(3)			Represents shares withheld/cash paid for the payment of payroll taxes.

We recorded stock-based compensation expense, which is included in General, administrative and other expenses, for stock options of $550,000 and $735,000, for the three months ended June 30, 2022 and 2023, respectively and $1,188,000 and $1,445,000 for the six months ended June 30, 2022 and 2023, respectively.


	Three months ended June 30,						Six months ended June 30,
	2022			2023			2022			2023
	Shares	Fair Value		Shares	Fair Value		Shares	Fair Value		Shares	Fair Value
Granted	23,263	$	1,100	—	$	—	27,013	$	1,262	—	$	—
Cancelled	13,974	$	134	2,795	$	27	20,961	$	201	40,181	$	1,012

We recorded stock-based compensation expense, which is included in General, administrative and other expenses, for performance awards of $637,000 and $665,000 for the three months ended June 30, 2022 and 2023, respectively and $1,203,000 and $728,000 for the six months ended June 30, 2022 and 2023, respectively.


	Three months ended June 30,						Six months ended June 30,
	2022			2023			2022			2023
	Shares	Price		Shares	Price		Shares	Price		Shares	Price
ESPP	11,796	$	33.70	16,386	$	24.28	25,089	$	39.86	38,042	$	24.28

The fair value of the right (option) to purchase shares under the ESPP is estimated at the date of purchase with the four quarterly purchase dates using the following assumptions:

We recorded stock-based compensation expense, which is included in General, administrative and other expenses and Regional and unallocated funeral and cemetery costs, for the ESPP totaling $152,000 and $163,000 for the three months ended June 30, 2022 and 2023, respectively and $351,000 and $415,000 for the six months ended June 30, 2022 and 2023 respectively.


	Three months ended June 30,						Six months ended June 30,
	2022			2023			2022			2023
	Shares	Fair Value		Shares	Fair Value		Shares	Fair Value		Shares	Fair Value
Granted(1)	—	$	—	—	$	—	—	$	—	30,000	$	826
Returned for payroll taxes	—	$	—	—	$	—	—	$	—	1,001	$	28

(1)

During the six months ended June 30, 2023, we issued 30,000 shares of common stock to a former executive at a stock price of $27.54, in accordance with his Separation and Release agreement pertaining to his resignation from his position as the Company's Executive Vice President, Chief Financial Officer & Treasurer effective January 2, 2023.

We recorded stock-based compensation expense, which is included in General, administrative and other expenses, for common stock awards of $826,000, for the six months ended June 30, 2023.

During the six months ended June 30, 2023, we issued 8,444 shares of our common stock to certain employees, which were valued at $0.3 million at a grant date stock price of $32.69. During the six months ended June 30, 2022, we issued 27,448 shares of our common stock to certain employees, which were valued at $1.4 million at a grant date stock price of $49.48.


	Three months ended June 30,						Six months ended June 30,
	2022			2023			2022			2023
	Shares	Fair Value		Shares	Fair Value		Shares	Fair Value		Shares	Fair Value
Board of Directors(1)	2,372	$	94	1,077	$	35	5,041	$	236	4,595	$	142
Advisor to the Board(1)	126	$	5	153	$	5	219	$	10	316	$	10

(1)

Common stock granted during the three months ended June 30, 2022 and 2023 had a weighted average price of $39.65 and $32.47, respectively and $46.83 and $31.01 for six months ended June 30, 2022 and 2023, respectively.

On June 21, 2023, the Board elected Chad Fargason to serve as a Class II Director until the 2025 annual meeting of shareholders. Mr. Fargason was appointed to serve as the chairperson of the Corporate Governance Committee and a member of the Audit Committee. Concurrently with his appointment, the Board granted Mr. Fargason 910 shares of our common stock under our Director Compensation Policy, which were valued at approximately $25,000 based on the closing price on the grant date.

We recorded compensation expense, which is included in General, administrative and other expenses, related to annual retainers, including the value of stock granted to non-employee Directors and an advisor to our Board, of $184,000 and $189,000 for the three months ended June 30, 2022 and 2023, respectively and $385,000 and $355,000 for the six months ended June 30, 2022 and 2023, respectively.


	Three months ended June 30,				Six months ended June 30,
	2022		2023		2022		2023
Number of Shares Repurchased	205,496		—		695,496		—
Average Price Paid Per Share	$	40.02	$	—	$	49.22	$	—
Dollar Value of Shares Repurchased	$	8,224	$	—	$	34,234	$	—

Our shares were purchased in the open market at times and in amounts as management determined appropriate based on factors such as market conditions, legal requirements and other business considerations. Shares purchased pursuant to the repurchase program are currently held as treasury stock. At June 30, 2023, our share repurchase program had $48.9 million authorized for repurchases.